N-Acetyl Glucosamine (NAG)
Summary
N-acetyl glucosamine is an amino sugar used to build cartilage, hyaluronic acid and the gut lining. In a 16-week placebo-controlled trial in 68 healthy adults, 500–1,000 mg a day did not change cartilage markers overall (grade D). Small open-label studies in multiple sclerosis and childhood inflammatory bowel disease reported favourable changes, but had no placebo group.
Key facts
- An amino sugar built into glycosaminoglycans such as hyaluronic acid[3]
- 500 or 1,000 mg a day for 16 weeks did not change cartilage breakdown or synthesis markers overall versus placebo; a subgroup with worse markers improved[1]
- Added to glatiramer acetate, 6–12 g a day for 4 weeks lowered blood inflammatory markers and neurofilament light in an open-label study[2]
- NAG is chemically distinct from glucosamine sulfate; trials of one do not test the other[1]
- 3 graded human outcomes on this page
- October 11, 2026
How it works
ProposedGlcNAc is a building block for glycosaminoglycans and for branched N-glycans on immune-cell proteins; raising its supply is proposed to support tissue repair and to damp T-cell activation.[2][3]
What the human research says
Human trials only, one row per outcome. The form column shows what each trial actually tested. Grades follow our evidence-grading policy.
At a glance: strongest evidence per outcome
| Outcome | Grade | Effect | Strongest evidence | Rows |
|---|---|---|---|---|
| Joints | Grade D | No effect | RCT · n = 68 · 2017 | 1 row |
| Multiple sclerosis | Grade D | Improved | Open-label · n = 34 · 2023 | 1 row |
| Gut | Grade D | Improved | Open-label · n = 12 · 2000 | 1 row |
Every graded row
| Outcome | Effect | Grade | Best evidence | PMID |
|---|---|---|---|---|
| Cartilage turnover markers in healthy adults | No effect | Grade D | RCT · n = 68 · 2017 Healthy Japanese adults without arthritis symptoms Form: N-acetyl glucosamine · Dose: 500 or 1,000 mg/day · Duration: 16 weeks No change in type II collagen breakdown or synthesis markers overall; in a subgroup with worse baseline markers, breakdown (C2C) fell versus placebo. No supplement-related adverse events. | 28413518 (opens PubMed)Source [1] |
| Inflammatory and nerve-damage blood markers in multiple sclerosis | Improved | Grade D | Open-label trial · n = 34 · 2023 Adults with MS on glatiramer acetate, not in relapse Form: N-acetyl glucosamine (oral) · Dose: 6 g/day (n = 18) or 12 g/day (n = 16) · Duration: 4 weeks Dose-dependent falls in IFNγ, IL-17, IL-6 and neurofilament light, but also in the anti-inflammatory cytokine IL-10; safe over 4 weeks. | 37705084 (opens PubMed)Source [2] |
| Disease activity in severe childhood inflammatory bowel disease | Improved | Grade D | Open-label trial · n = 12 · 2000 Children with treatment-resistant Crohn disease or ulcerative colitis Form: N-acetyl glucosamine (oral, add-on) · Dose: 3–6 g/day · Duration: Not stated in the abstract (follow-up over 2.5 years) 8 of 12 improved clearly; 4 needed surgery. Biopsies showed more glycosaminoglycans in the gut lining. | 11121904 (opens PubMed)Source [3] |
Forms
| Form | Elemental % | Absorption (human data) | GI tolerance | Studied for |
|---|---|---|---|---|
| N-acetyl glucosamine | Varies[1] | No head-to-head human absorption data with glucosamine sulfate in our sources.[1] | No supplement-related adverse events at up to 1,000 mg a day for 16 weeks; 6–12 g a day for 4 weeks was reported safe in the MS study.[1][2] | Cartilage markers, MS markers, childhood IBD |
Studied doses
Doses studied in human trials ranged from 500 mg a day (16 weeks, healthy adults) to 12 g a day (4 weeks, multiple sclerosis).[1][2]
Interactions
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
None found in our sources.
Who should be careful
- Shellfish allergy
- The product label we checked warns against use with a shellfish allergy; check the source of the NAG you buy.[4]
- People with MS or inflammatory bowel disease
- The supporting studies were small, open-label add-ons to standard care; they do not replace it.[2][3]
- Pregnancy and breastfeeding
- No safety data in the trials we cite.[1]
Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.
Where to buy N-Acetyl Glucosamine (NAG)
Products from brands we partner with that contain N-Acetyl Glucosamine (NAG). Listing a product is not a claim that it works; check the amount per serving against the doses studied above, and the label for other ingredients.
- SupersmartPaid linkNAG Supplement3 capsules: 1,500 mg N-acetyl glucosamine; 30 servings. Above the 500–1,000 mg a day tested in healthy adults and well below the 6–12 g a day used in the MS study. The label warns against use with a shellfish allergy.Shop at Supersmart (opens in new tab)Price and label checked 2026-10-11 on the brand’s site.
Partner links may earn us a commission. Learn more
Get 15% off with SMART026 (opens in new tab)15% off with code SMART026
Partner links may earn us a commission. Learn more
- Supersmart’s own terms and exclusions apply at checkout.
- 20% applies when 3 or more products ship on auto-delivery to the same address.
- The code discount and Subscribe & Save are separate offers; we don’t claim they combine.
- Offer terms from Supersmart’s site and its affiliate program, checked Oct 8, 2026. Offers can change; the brand's checkout is final.
Frequently asked questions
Is NAG better than glucosamine sulfate?
There are no head-to-head human trials in our sources. They are different molecules, so results for glucosamine sulfate do not carry over.[1]
Does NAG help joints?
In healthy adults, 500–1,000 mg a day did not change cartilage markers overall over 16 weeks. Trials in people with arthritis are lacking in our sources.[1]
Is NAG used for gut health?
A small uncontrolled pilot in children with severe inflammatory bowel disease reported improvement in 8 of 12; controlled trials are still needed.[3]
Is NAG safe with a shellfish allergy?
Check the product. The label we checked warns against use with a shellfish allergy.[4]
Sources
- [1]Effect of N-acetylglucosamine administration on cartilage metabolism and safety in healthy subjects without symptoms of arthritis: A case report.. Exp Ther Med, 2017. RCT
- [2]N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial.. J Neuroinflammation, 2023. open-label
- [3]A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease.. Aliment Pharmacol Ther, 2000. open-label
- [4]NAG Supplement: Supplement Facts and cautions. Supersmart, 2026. label
What changed
- First draft. Every PMID checked against NCBI E-utilities (title, year and journal taken from the PubMed record) and abstracts read for each cited row. Product details in Where to buy read from the brand page on the date shown. Self-reviewed in a second strict pass, then checked by an independent adversarial fact-check against the PubMed abstracts and live product pages. No credentialed medical reviewer yet.